Fracture risk increases following cancer therapies for advanced prostate cancer

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study

Geriatric interventions are beneficial in reducing treatment-related toxicity in older adults with cancer

Understanding the remaining unmet needs in a post ASCT NDMM setting

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM

ESMO and WCLC: Latest developments in EGFR mutated NSCLC

Multiple Myeloma: evolving paradigm - Panel Discussion

New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy-induced nausea and vomiting in NSCLC patients

Advancements in paediatric Acute lymphoblastic leukemia management

Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients

Amivantamab-lazertinib continue to show benefit as a first-line standard-of-care for EGFR-mutated advanced NSCLC

Choosing the right patients for transplant